Gallbladder Cancer

Fast Facts:

  • Most common biliary tract malignancy.
  • Extremely lethal if symptomatic at presentation (mean survival ≈ 6 months).
  • Associated with gallstones and chronic inflammation (incidentally found at surgery in ≈ 2% of routine cholecystectomy patients).

PET/CT Interpretation of Gallbladder Activity:   

The normal gallbladder typically demonstrates little or no FDG uptake.

Mild to moderate diffuse gallbladder uptake is usually normal.

Intense diffuse gallbladder uptake in an otherwise normal appearing gallbladder often represents normal physiologic uptake. Ultrasound correlation, however, is still typically recommended: “Ultrasound correlation may be of diagnostic value, if clinically warranted.

Diffuse intense gallbladder uptake associated with wall thickening, pericholecystic fluid or gallstones is suspicious for cholecystitis.  In such cases, ultrasound correlation is strongly recommended, “Ultrasound correlation is recommended in this case to exclude acute cholecystitis.”

While focal intense gallbladder wall uptake can be seen with benign polyps, adenomyomatosis or focal inflammation associated with cholecystitis, malignancy must be excluded.

False Positives:    

  • Normal Physiologic Uptake
  • Polyps & Adenomyomatosis
  • Cholcystitis, Acute or Chronic

Indications for PET/CT:

Initial Staging of Gallbladder Carcinoma: 

  • While PET/CT can detect the primary lesion, its true utility lies in the detection of regional nodes and distant metastatic disease.
  • Distant Disease: Most commonly to the liver, lung and brain.

Assessing Response to Therapy & Prognosis: 

  • Early Response: Non-responders can be offered alternative therapy.
  • Late Response: Assess success or failure of therapy, and ultimate outcome.

Recurrence & Restaging: 

  • Restaging suspected recurrence.
  • Distinguishing recurrence from post-therapeutic inflammation.